https://koreaequitylens.com/ 2026-08-24T09:23:58+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-dram-pricing-%c2%b7-big-tech-demand-%c2%b7-earnings-upgrades-2026-01-19/ 2026-08-24T09:23:58+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-eugene-investment-hbm-demand-%c2%b7-ai-accelerator-diversification-%c2%b7-profitability-2026-01-21/ 2026-08-24T09:19:51+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-sk-securities-lta-%c2%b7-capex-discipline-%c2%b7-cycle-stability-2026-01-28/ 2026-08-24T09:17:18+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-yuanta-ai-inference-%c2%b7-enterprise-ssd-%c2%b7-cash-flow-2026-01-29/ 2026-08-24T08:53:53+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hyundai-motor-supply-shortage-%c2%b7-memory-asp-%c2%b7-profitability-2026-01-30/ 2026-08-24T08:52:45+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-ds-investment-server-memory-demand-%c2%b7-hbm3e-pricing-%c2%b7-margin-expansion-2026-01-30/ 2026-08-24T08:51:31+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-kyobo-ai-server-demand-%c2%b7-memory-asp-%c2%b7-high-value-product-mix-2026-01-30/ 2026-08-24T08:50:17+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hana-memory-pricing-%c2%b7-cash-flow-%c2%b7-shareholder-returns-2026-01-30/ 2026-08-24T08:49:09+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-memory-pricing-%c2%b7-operating-leverage-%c2%b7-shareholder-returns-2026-01-30/ 2026-08-24T08:43:19+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-daishin-capex-discipline-%c2%b7-multi-year-lta-%c2%b7-shareholder-returns-2026-01-30/ 2026-08-24T08:42:06+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-eugene-investment-hbm-%c2%b7-essd-%c2%b7-margin-expansion-2026-01-30/ 2026-08-24T08:40:25+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-shinhan-memory-asp-%c2%b7-supply-tightness-%c2%b7-pricing-power-2026-01-30/ 2026-08-24T08:39:13+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-im-securities-fixed-memory-pricing-%c2%b7-supply-shortage-%c2%b7-earnings-growth-2026-01-30/ 2026-08-24T08:38:08+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-kiwoom-commodity-memory-pricing-%c2%b7-server-demand-%c2%b7-earnings-upgrades-2026-01-30/ 2026-08-24T08:36:16+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-daishin-legacy-memory-pricing-%c2%b7-lta-%c2%b7-adr-2026-02-23/ 2026-08-24T08:35:02+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-sk-securities-ai-memory-%c2%b7-nand-tiering-%c2%b7-earnings-re-rating-2026-02-24/ 2026-08-24T08:33:05+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-kiwoom-legacy-memory-pricing-%c2%b7-earnings-upgrades-%c2%b7-volume-growth-2026-03-03/ 2026-08-24T08:32:01+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-memory-pricing-%c2%b7-supply-deficit-%c2%b7-valuation-appeal-2026-03-04/ 2026-08-24T08:30:52+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-daishin-memory-asp-%c2%b7-earnings-upgrades-%c2%b7-valuation-appeal-2026-03-16/ 2026-08-24T08:29:45+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-memory-pricing-%c2%b7-adr-listing-%c2%b7-valuation-re-rating-2026-03-23/ 2026-08-24T08:27:57+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-adr-listing-%c2%b7-valuation-gap-%c2%b7-re-rating-2026-03-25/ 2026-08-24T08:26:11+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-im-securities-memory-asp-%c2%b7-server-demand-%c2%b7-earnings-upgrades-2026-03-31/ 2026-08-24T08:20:22+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-memory-pricing-resilience-%c2%b7-earnings-visibility-%c2%b7-valuation-appeal-2026-04-01/ 2026-08-24T08:19:09+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hana-memory-pricing-%c2%b7-earnings-upgrades-%c2%b7-lta-2026-04-02/ 2026-08-24T08:17:53+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-multi-year-lta-%c2%b7-price-downside-protection-%c2%b7-roe-sustainability-2026-04-06/ 2026-08-24T08:16:47+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-shinhan-memory-pricing-%c2%b7-lta-%c2%b7-supplier-pricing-power-2026-04-06/ 2026-08-24T08:15:34+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-ds-investment-contract-pricing-%c2%b7-lta-%c2%b7-dram-supply-shortage-2026-04-09/ 2026-08-24T08:13:50+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-kiwoom-server-dram-%c2%b7-essd-%c2%b7-earnings-upgrades-2026-04-09/ 2026-08-24T08:11:56+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-ibk-securities-ai-servers-%c2%b7-server-dram-%c2%b7-supply-tightness-2026-04-15/ 2026-08-24T08:10:14+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-meritz-adr-listing-%c2%b7-valuation-discount-%c2%b7-re-rating-2026-04-23/ 2026-08-24T08:02:36+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-ds-investment-memory-asp-%c2%b7-high-value-product-mix-%c2%b7-supply-tightness-2026-04-23/ 2026-08-24T08:01:26+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-yuanta-memory-pricing-%c2%b7-long-term-contracts-%c2%b7-earnings-stability-2026-04-23/ 2026-08-24T08:00:21+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-memory-pricing-%c2%b7-lta-%c2%b7-supply-tightness-2026-04-23/ 2026-08-24T07:58:48+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-kyobo-agentic-ai-%c2%b7-high-value-memory-%c2%b7-pricing-momentum-2026-04-24/ 2026-08-24T07:57:27+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hana-lpddr-demand-%c2%b7-mobile-dram-tightness-%c2%b7-earnings-growth-2026-04-24/ 2026-08-24T07:56:22+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hanwha-lta-%c2%b7-hbm-%c2%b7-earnings-sustainability-2026-04-24/ 2026-08-24T07:55:10+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-daishin-supply-constraints-%c2%b7-multi-year-lta-%c2%b7-shareholder-returns-2026-04-24/ 2026-08-24T07:54:07+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-shinhan-supply-constraints-%c2%b7-memory-pricing-%c2%b7-lta-2026-04-24/ 2026-08-24T07:48:18+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-im-securities-dram-pricing-%c2%b7-adr-listing-%c2%b7-multiple-recovery-2026-04-24/ 2026-08-24T07:47:15+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-ibk-securities-ai-servers-%c2%b7-full-stack-memory-%c2%b7-nand-demand-2026-04-24/ 2026-08-24T07:45:23+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-agentic-ai-%c2%b7-server-cpu-%c2%b7-lpddr-2026-04-28/ 2026-08-24T07:43:39+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-hyperscaler-capex-%c2%b7-custom-hbm-%c2%b7-inference-memory-demand-2026-05-04/ 2026-08-24T07:42:29+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-eugene-investment-server-memory-demand-%c2%b7-lta-%c2%b7-hbm-leadership-2026-05-04/ 2026-08-24T07:40:08+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-server-cpu-demand-%c2%b7-hbm-diversification-%c2%b7-hbm4-2026-05-07/ 2026-08-24T07:38:57+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-ai-data-center-backlogs-%c2%b7-lta-%c2%b7-earnings-visibility-2026-05-11/ 2026-08-24T07:37:14+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-kiwoom-commodity-memory-pricing-%c2%b7-supply-constraints-%c2%b7-earnings-surge-2026-05-11/ 2026-08-24T07:35:42+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hyundai-motor-agentic-ai-%c2%b7-memory-demand-%c2%b7-cycle-stability-2026-05-13/ 2026-08-24T07:32:28+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-enterprise-ssd-%c2%b7-nand-pricing-%c2%b7-profitability-2026-05-18/ 2026-08-24T07:31:24+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-shinhan-supply-constraints-%c2%b7-memory-pricing-%c2%b7-earnings-growth-2026-05-21/ 2026-08-24T07:30:09+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-lta-%c2%b7-hbm-demand-%c2%b7-valuation-re-rating-2026-05-27/ 2026-08-24T07:23:33+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-adr-listing-%c2%b7-phlx-inclusion-%c2%b7-valuation-re-rating-2026-06-01/ 2026-08-24T07:22:27+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-ai-infrastructure-%c2%b7-lta-%c2%b7-hbm-demand-2026-06-09/ 2026-08-24T07:20:45+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hanwha-lta-%c2%b7-hbm-%c2%b7-valuation-re-rating-2026-06-22/ 2026-08-24T07:19:40+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-adr-listing-%c2%b7-sox-inclusion-%c2%b7-hbm-pricing-2026-06-25/ 2026-08-24T07:14:27+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hana-commodity-dram-pricing-%c2%b7-lta-%c2%b7-multiple-expansion-2026-06-26/ 2026-08-24T07:12:43+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-shinhan-adr-listing-%c2%b7-hbm-pricing-%c2%b7-valuation-re-rating-2026-06-30/ 2026-08-24T07:09:37+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-kyobo-agentic-ai-%c2%b7-hbm-market-share-%c2%b7-earnings-growth-2026-07-01/ 2026-08-24T07:08:33+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-daishin-adr-listing-%c2%b7-hbm4-%c2%b7-valuation-re-rating-2026-07-07/ 2026-08-24T07:07:22+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hyundai-motor-lta-%c2%b7-premium-product-mix-%c2%b7-blended-asp-2026-07-14/ 2026-08-24T07:06:19+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-big-tech-backlogs-%c2%b7-memory-supply-tightness-%c2%b7-earnings-growth-2026-07-14/ 2026-08-24T07:05:15+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-ds-investment-commodity-dram-%c2%b7-asp-resilience-%c2%b7-earnings-growth-2026-07-29/ 2026-08-24T07:03:34+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-roe-expansion-%c2%b7-net-cash-%c2%b7-shareholder-returns-2026-07-29/ 2026-08-24T07:01:46+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-kyobo-hbm4-%c2%b7-product-mix-%c2%b7-lta-2026-07-30/ 2026-08-24T07:00:38+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hanwha-lta-%c2%b7-earnings-floor-%c2%b7-cycle-stability-2026-07-30/ 2026-08-24T06:55:31+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-hana-hbm4-%c2%b7-lta-%c2%b7-valuation-appeal-2026-07-30/ 2026-08-24T06:54:27+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-daishin-supply-discipline-%c2%b7-lta-%c2%b7-shareholder-returns-2026-07-30/ 2026-08-24T06:52:20+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-shinhan-ultra-low-inventory-%c2%b7-supply-shortage-%c2%b7-earnings-rebound-2026-07-30/ 2026-08-24T06:50:33+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-kiwoom-commodity-memory-pricing-%c2%b7-hbm4-%c2%b7-valuation-appeal-2026-07-30/ 2026-08-24T06:48:39+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-sk-securities-supply-tightness-%c2%b7-lta-%c2%b7-shareholder-returns-2026-07-30/ 2026-08-24T06:47:27+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-eugene-investment-ai-infrastructure-%c2%b7-memory-shortage-%c2%b7-product-mix-2026-07-31/ 2026-08-24T06:45:11+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-sk-securities-lta-%c2%b7-earnings-visibility-%c2%b7-shareholder-returns-2026-08-03/ 2026-08-24T06:42:21+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-solidigm-monetization-%c2%b7-shareholder-returns-%c2%b7-valuation-appeal-2026-08-11/ 2026-08-24T06:40:21+00:00 https://koreaequitylens.com/research-sk-hynix-000660-skhy-mirae-asset-dram-supply-demand-%c2%b7-ai-infrastructure-finance-%c2%b7-valuation-re-rating-2026-08-14/ 2026-08-24T06:39:19+00:00 https://koreaequitylens.com/research-celltrion-068270-ibk-securities-new-biosimilar-mix-expansion-%c2%b7-operating-leverage-%c2%b7-h2-margin-expansion-2026-05-07/ 2026-08-23T11:20:20+00:00 https://koreaequitylens.com/research-celltrion-068270-ks-sk-securities-new-portfolio-mix-expansion-%c2%b7-operating-leverage-%c2%b7-h2-product-launches-2026-05-07/ 2026-08-23T11:18:14+00:00 https://koreaequitylens.com/research-celltrion-068270-yuanta-securities-new-biosimilar-growth-%c2%b7-facility-expansion-%c2%b7-cmo-capacity-readiness-2026-05-07/ 2026-08-23T11:15:59+00:00 https://koreaequitylens.com/research-celltrion-068270-ds-investment-securities-2nd-gen-biosimilar-penetration-%c2%b7-cogs-ratio-stabilization-%c2%b7-global-capacity-expansion-2026-05-07/ 2026-08-23T11:13:53+00:00 https://koreaequitylens.com/research-celltrion-068270-shinhan-securities-new-product-sales-expansion-%c2%b7-operating-leverage-%c2%b7-global-cmo-contracts-2026-05-15/ 2026-08-23T10:57:44+00:00 https://koreaequitylens.com/research-celltrion-068270-daishin-securities-merger-noise-resolution-%c2%b7-portfolio-expansion-leverage-%c2%b7-cmo-revenue-visibility-2026-05-19/ 2026-08-23T10:54:46+00:00 https://koreaequitylens.com/research-celltrion-068270-im-securities-new-product-mix-expansion-%c2%b7-first-mover-advantage-%c2%b7-two-track-long-term-strategy-2026-07-28/ 2026-08-23T10:50:42+00:00 https://koreaequitylens.com/research-celltrion-068270-shinhan-securities-north-american-new-product-penetration-%c2%b7-2030-pipeline-%c2%b7-new-drug-cycle-2026-07-28/ 2026-08-23T10:48:50+00:00 https://koreaequitylens.com/research-celltrion-068270-mirae-asset-securities-new-product-mix-expansion-%c2%b7-in-house-cost-efficiency-%c2%b7-valuation-vs-peers-2026-07-28/ 2026-08-23T10:45:26+00:00 https://koreaequitylens.com/research-celltrion-068270-daishin-securities-new-product-mix-%c2%b7-h2-margin-expansion-%c2%b7-new-drug-pipeline-2026-07-28/ 2026-08-23T10:42:59+00:00 https://koreaequitylens.com/research-celltrion-068270-yuanta-securities-new-product-mix-expansion-%c2%b7-pipeline-addition-%c2%b7-earnings-growth-2026-07-28/ 2026-08-23T10:41:08+00:00 https://koreaequitylens.com/research-celltrion-068270-ks-sk-securities-2q26-re-profitability-inflection-underway-%c2%b7-operating-leverage-in-focus-%c2%b7-robust-h2-momentum-2026-08-03/ 2026-08-23T10:37:41+00:00 https://koreaequitylens.com/research-celltrion-068270-ds-investment-securities-2q26-re-steep-growth-exceeds-expectations-%c2%b7-new-biosimilars-surge-%c2%b7-large-cap-top-pick-2026-07-28/ 2026-08-23T10:36:08+00:00 https://koreaequitylens.com/research-alteogen-196170-hana-securities-gsk-single-asset-deal-analysis-%c2%b7-expanding-sc-competitiveness-%c2%b7-ongoing-2026-deal-catalysts-2026-01-21/ 2026-08-23T10:21:31+00:00 https://koreaequitylens.com/research-alteogen-196170-shinhan-securities-gsk-deal-supports-low-patent-risk-view-%c2%b7-keytruda-sc-royalty-calibrated-%c2%b7-target-price-adjusted-2026-01-21/ 2026-08-23T10:18:34+00:00 https://koreaequitylens.com/research-alteogen-196170-hana-securities-target-price-adjusted-on-royalty-structure-deal-assumptions-%c2%b7-deal-acceleration-starts-in-2026-2026-01-22/ 2026-08-23T10:15:32+00:00 https://koreaequitylens.com/research-alteogen-196170-hana-securities-core-business-on-track-%c2%b7-favorable-deal-outlook-%c2%b7-keytruda-royalty-impact-reflected-2026-02-19/ 2026-08-23T10:12:17+00:00 https://koreaequitylens.com/research-alteogen-196170-shinhan-securities-first-uk-patent-ruling-favors-merck-%c2%b7-positive-read-across-to-global-disputes-%c2%b7-pipeline-out-licensing-ahead-2026-02-23/ 2026-08-23T10:08:57+00:00 https://koreaequitylens.com/research-alteogen-196170-hana-securities-exclusive-biogen-licensing-deal-%c2%b7-usd-40m-q1-cumulative-upfronts-%c2%b7-rich-q2-catalysts-ahead-2026-03-26/ 2026-08-23T10:07:03+00:00 https://koreaequitylens.com/research-alteogen-196170-shinhan-securities-2-out-licensing-deals-in-q1-%c2%b7-biogen-deal-analysis-%c2%b7-major-catalysts-ahead-from-april-2026-03-27/ 2026-08-23T10:03:55+00:00 https://koreaequitylens.com/research-alteogen-196170-shinhan-securities-keytruda-sc-growth-accelerates-%c2%b7-favorable-contract-terms-%c2%b7-early-june-pgr-catalysts-2026-05-11/ 2026-08-23T10:00:04+00:00 https://koreaequitylens.com/research-alteogen-196170-hana-securities-steady-milestone-inflows-%c2%b7-interpreting-gsks-enhanze-deal-%c2%b7-pgr-final-ruling-catalysts-2026-05-13/ 2026-08-23T09:56:04+00:00 https://koreaequitylens.com/research-alteogen-196170-shinhan-securities-halozyme-patent-invalidated-%c2%b7-key-overhangs-materially-eased-%c2%b7-target-price-raised-2026-05-14/ 2026-08-23T09:53:13+00:00 https://koreaequitylens.com/research-alteogen-196170-daishin-securities-validated-alt-b4-platform-%c2%b7-keytruda-sc-milestones-accelerate-%c2%b7-coverage-initiation-2026-05-19/ 2026-08-23T09:50:36+00:00 https://koreaequitylens.com/research-alteogen-196170-daishin-securities-key-us-patent-risks-significantly-eased-%c2%b7-new-licensing-catalysts-%c2%b7-keytruda-sc-milestones-2026-06-02/ 2026-08-23T09:44:22+00:00 https://koreaequitylens.com/research-alteogen-196170-hana-securities-alt-b4-differentiation-potential-%c2%b7-enhanze-biosimilar-concerns-dispelled-%c2%b7-qlex-revenue-visibility-2026-07-15/ 2026-08-23T09:41:12+00:00 https://koreaequitylens.com/research-alteogen-196170-shinhan-securities-record-3-out-licensing-deals-in-2026-%c2%b7-rapid-keytruda-sc-rollout-%c2%b7-h2-clinical-pipeline-catalysts-2026-08-06/ 2026-08-23T09:35:04+00:00 https://koreaequitylens.com/research-alteogen-196170-hana-securities-new-alt-b4-deal-signed-%c2%b7-qlex-prescription-surge-%c2%b7-sc-conversion-acceleration-2026-08-06/ 2026-08-23T09:32:35+00:00 https://koreaequitylens.com/research-alteogen-196170-daishin-securities-keytruda-qlex-commercial-milestones-%c2%b7-rna-modality-expansion-%c2%b7-platform-re-rating-2026-08-10-2/ 2026-08-23T09:29:19+00:00 https://koreaequitylens.com/research-alteogen-196170-daishin-securities-keytruda-qlex-commercial-milestones-%c2%b7-rna-modality-expansion-%c2%b7-platform-re-rating-2026-08-10/ 2026-08-23T09:25:10+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-kiwoom-securities-plant-5-h2-revenue-recognition-%c2%b7-us-site-cost-control-%c2%b7-2026-profitability-defense-2026-01-07/ 2026-08-23T05:33:08+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-yuanta-securities-us-site-acquisition-%c2%b7-biosecure-act-beneficiary-%c2%b7-plant-6-campus-3-expansion-2026-01-07/ 2026-08-23T05:31:27+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-hana-securities-post-spinoff-profitability-%c2%b7-record-krw-6-8t-orders-%c2%b7-plant-6-groundbreaking-visibility-2026-01-07/ 2026-08-23T05:29:45+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-im-securities-spin-off-valuation-re-rating-%c2%b7-biosecure-act-inflows-%c2%b7-plant-6-groundbreaking-2026-01-09/ 2026-08-23T05:22:58+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-im-securities-annual-operating-profit-surpasses-krw-2t-%c2%b7-pure-cdmo-transition-%c2%b7-three-pillar-growth-strategy-2026-01-22/ 2026-08-23T05:21:03+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-kiwoom-securities-plant-6-groundbreaking-visibility-%c2%b7-labor-negotiation-%c2%b7-rockville-revenue-recognition-2026-04-02/ 2026-08-23T05:19:04+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-yuanta-securities-us-site-acquisition-%c2%b7-biosecure-act-beneficiary-%c2%b7-bio-campus-3-expansion-2026-04-02/ 2026-08-23T05:17:12+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-hana-securities-rockville-acquisition-finalized-%c2%b7-guidance-revision-outlook-%c2%b7-tariff-resilience-2026-04-02/ 2026-08-23T05:13:52+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-im-securities-us-site-operation-%c2%b7-k-cdmo-policy-support-%c2%b7-order-pipeline-optimization-2026-04-23/ 2026-08-23T05:11:46+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-ibk-securities-plant-5-ppq-revenue-%c2%b7-us-site-consolidation-%c2%b7-guidance-revision-potential-2026-04-23/ 2026-08-23T05:10:02+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-shinhan-securities-rockville-revenue-recognition-%c2%b7-guidance-revision-potential-%c2%b7-songdo-plant-6-groundbreaking-2026-04-23/ 2026-08-23T05:08:20+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-hana-securities-rockville-revenue-recognition-%c2%b7-guidance-revision-potential-%c2%b7-plant-5-commercialization-2026-04-23/ 2026-08-23T05:05:11+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-ds-investment-securities-plant-5-revenue-contribution-%c2%b7-us-plant-acquisition-%c2%b7-plant-6-groundbreaking-2026-04-23/ 2026-08-23T05:02:54+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-daishin-securities-plant-5-operation-%c2%b7-fixed-cost-operating-leverage-%c2%b7-plant-6-expansion-2026-05-19/ 2026-08-23T05:00:04+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-ibk-securities-plant-5-ramp-up-%c2%b7-resolution-of-labor-risk-%c2%b7-annual-guidance-delivery-2026-06-29/ 2026-08-23T04:56:58+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-shinhan-securities-wage-negotiation-factors-%c2%b7-rockville-ramp-up-%c2%b7-plant-6-catalyst-2026-07-01/ 2026-08-23T04:54:47+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-daishin-securities-peptide-market-entry-%c2%b7-global-footprint-expansion-%c2%b7-modality-diversification-2026-07-21/ 2026-08-23T04:52:58+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-kiwoom-securities-plant-5-rockville-ramp-up-%c2%b7-guidance-upside-%c2%b7-4q-earnings-concentration-2026-07-24/ 2026-08-23T04:51:19+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-im-securities-new-plant-operations-%c2%b7-polypeptide-acquisition-%c2%b7-portfolio-diversification-2026-07-24/ 2026-08-23T04:48:20+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-shinhan-securities-capacity-expansion-%c2%b7-peptide-entry-%c2%b7-guidance-upgrade-2026-07-24/ 2026-08-23T04:46:15+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-ibk-securities-us-operations-%c2%b7-plant-5-ramp-up-%c2%b7-peptide-expansion-2026-07-24/ 2026-08-23T04:43:46+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-daishin-securities-4q-earnings-recovery-%c2%b7-new-plant-ramp-up-%c2%b7-peptide-expansion-2026-07-24/ 2026-08-23T04:41:59+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-hana-securities-rockville-ramp-up-%c2%b7-business-scale-expansion-%c2%b7-revenue-visibility-2026-07-24/ 2026-08-23T04:39:17+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-kyobo-securities-h2-revenue-recognition-%c2%b7-modality-diversification-%c2%b7-earnings-growth-2026-07-24/ 2026-08-23T04:37:20+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-ds-investment-securities-order-recovery-%c2%b7-plant-ramp-up-%c2%b7-earnings-growth-2026-07-24/ 2026-08-23T04:34:25+00:00 https://koreaequitylens.com/research-samsung-biologics-207940-mirae-asset-plant-5-ramp-up-%c2%b7-cdmo-expansion-%c2%b7-earnings-forecast-2026-07-27/ 2026-08-23T04:32:58+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q2-2026-earnings-presentation-2026-07-30/ 2026-08-23T04:11:34+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q4-2024-earnings-presentation-2025-01-31/ 2026-08-23T04:06:07+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q2-2025-earnings-presentation-2025-07-31/ 2026-08-23T03:57:58+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q4-2023-earnings-presentation-2024-01-25/ 2026-08-23T03:57:05+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q4-2023-earnings-presentation-2024-01-31/ 2026-08-23T03:56:07+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q4-2023-earnings-presentation-2024-01-31/ 2026-08-23T03:55:10+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q1-2024-earnings-presentation-2024-04-25/ 2026-08-23T03:54:02+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q1-2024-earnings-presentation-2024-04-29/ 2026-08-23T03:53:01+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q1-2024-earnings-presentation-2024-04-30/ 2026-08-23T03:52:03+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q2-2024-earnings-presentation-2024-07-25/ 2026-08-23T03:51:02+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q2-2024-earnings-presentation-2024-07-31/ 2026-08-23T03:48:28+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q2-2024-earnings-presentation-2024-07-31/ 2026-08-23T03:47:25+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q3-2024-earnings-presentation-2024-10-24/ 2026-08-23T03:46:14+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q3-2024-earnings-presentation-2024-10-29/ 2026-08-23T03:45:11+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q3-2024-earnings-presentation-2024-10-31/ 2026-08-23T03:44:05+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q4-2024-earnings-presentation-2025-01-23/ 2026-08-23T03:43:04+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q4-2024-earnings-presentation-2025-01-24/ 2026-08-23T03:41:12+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q1-2025-earnings-presentation-2025-04-24/ 2026-08-23T03:39:59+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q1-2025-earnings-presentation-2025-04-29/ 2026-08-23T03:38:54+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q1-2025-earnings-presentation-2025-04-30/ 2026-08-23T03:37:05+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q2-2025-earnings-presentation-2025-07-24/ 2026-08-23T03:36:00+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q2-2025-earnings-presentation-2025-07-31/ 2026-08-23T03:28:34+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q3-2025-earnings-presentation-2025-10-29/ 2026-08-23T03:27:28+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q3-2025-earnings-presentation-2025-10-29/ 2026-08-23T03:26:12+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q3-2025-earnings-presentation-2025-10-30/ 2026-08-23T03:24:08+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q4-2025-earnings-presentation-2026-01-23/ 2026-08-23T03:22:21+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q4-2025-earnings-presentation-2026-01-29/ 2026-08-23T03:21:24+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q4-2025-earnings-presentation-2026-01-29/ 2026-08-23T03:20:12+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q1-2026-earnings-presentation-2026-04-23/ 2026-08-23T03:19:06+00:00 https://koreaequitylens.com/ir-samsung-electro-mechanics-009150-q1-2026-earnings-presentation-2026-04-30/ 2026-08-23T03:17:26+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q1-2026-earnings-presentation-2026-04-30/ 2026-08-23T03:15:20+00:00 https://koreaequitylens.com/ir-sk-hynix-000660-skhy-q2-2026-earnings-presentation-2026-07-29/ 2026-08-23T03:14:10+00:00 https://koreaequitylens.com/ir-samsung-electronics-005930-q2-2026-earnings-presentation-2026-07-30/ 2026-08-23T03:12:10+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-ds-investment-securities-low-price-mix-reduction-%c2%b7-merchant-margin-step-up-%c2%b7-masga-defense-pipeline-2026-04-28/ 2026-08-22T08:51:08+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-hanwha-merchant-margin-surprise-%c2%b7-high-price-mix-expansion-%c2%b7-special-ship-fixed-cost-absorption-2026-04-28/ 2026-08-22T08:47:23+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-kiwoom-merchant-profit-driver-%c2%b7-high-price-mix-scale-up-%c2%b7-naval-offshore-orders-2026-04-29/ 2026-08-22T08:45:47+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-yuanta-merchant-mix-improvement-%c2%b7-cpsp-project-value-%c2%b7-masga-catalysts-2026-07-06/ 2026-08-22T08:33:02+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-daishin-early-offshore-revenue-%c2%b7-naval-defense-pipeline-%c2%b7-excessive-discount-2026-07-09/ 2026-08-22T08:29:53+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-sk-securities-merchant-margin-growth-%c2%b7-offshore-order-requirements-%c2%b7-global-naval-pipeline-2026-07-13/ 2026-08-22T08:27:47+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-kiwoom-merchant-earnings-growth-%c2%b7-2h-order-momentum-%c2%b7-us-naval-defense-2026-07-15/ 2026-08-22T08:26:00+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-kiwoom-high-price-mix-%c2%b7-merchant-margin-acceleration-%c2%b7-2h-order-intake-2026-07-28/ 2026-08-22T08:24:09+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-im-securities-merchant-profit-surprise-%c2%b7-special-ship-sentiment-%c2%b7-valuation-de-rating-2026-07-28/ 2026-08-22T08:22:25+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-shinhan-merchant-profit-level-up-%c2%b7-special-ship-order-variables-%c2%b7-balanced-portfolio-2026-07-28/ 2026-08-22T08:20:39+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-sk-securities-merchant-margin-surprise-%c2%b7-cost-incentive-factors-%c2%b7-earnings-volatility-2026-07-28/ 2026-08-22T08:18:39+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-eugene-high-price-order-mix-%c2%b7-merchant-margin-continuity-%c2%b7-special-ship-pipeline-2026-07-28/ 2026-08-22T08:16:58+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-yuanta-merchant-vessel-margin-%c2%b7-fx-gains-%c2%b7-earnings-differentiation-2026-07-28/ 2026-08-22T08:11:21+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-hana-securities-merchant-vessel-margin-expansion-%c2%b7-energy-supply-chain-shift-%c2%b7-order-momentum-2026-07-28/ 2026-08-22T08:08:49+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-ds-investment-securities-merchant-vessel-profitability-%c2%b7-high-price-mix-%c2%b7-masga-beneficiary-2026-07-28/ 2026-08-22T08:07:10+00:00 https://koreaequitylens.com/research-hanwha-ocean-042660-daishin-merchant-vessel-margin-%c2%b7-fx-impact-%c2%b7-us-navy-logistics-synergy-2026-07-29/ 2026-08-22T08:00:00+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-hanwha-investment-securities-delayed-ev-recovery-%c2%b7-ess-highlights-as-sole-driver-%c2%b7-target-price-cut-2026-01-07/ 2026-08-22T07:47:02+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-mirae-asset-securities-hypothetical-sdc-stake-monetization-%c2%b7-north-american-ess-acceleration-%c2%b7-valuation-appeal-2026-01-19/ 2026-08-22T07:44:21+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-kiwoom-securities-near-term-sluggishness-but-intact-momentum-%c2%b7-4q26-turnaround-%c2%b7-solid-state-pipeline-2026-02-03/ 2026-08-22T07:42:29+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-im-securities-us-ess-market-share-gains-%c2%b7-mid-term-ess-op-of-krw-1-4t-%c2%b7-4q-loss-narrowing-2026-02-03/ 2026-08-22T07:39:53+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-ibk-securities-accelerating-north-american-ess-conversions-%c2%b7-fy26-ampc-krw-359b-%c2%b7-4q-in-line-2026-02-03/ 2026-08-22T07:32:35+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-shinhan-securities-expanding-north-american-ess-momentum-%c2%b7-sole-non-china-prismatic-maker-%c2%b7-4q-in-line-2026-02-03/ 2026-08-22T07:29:46+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-ks-sk-securities-prominent-base-effects-%c2%b7-conservative-capex-management-%c2%b7-compelling-valuation-2026-02-03/ 2026-08-22T07:20:21+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-mirae-asset-securities-commencing-customer-t-ess-business-estimated-%c2%b7-sdc-asset-utilization-%c2%b7-valuation-gap-narrowing-2026-02-03/ 2026-08-22T07:03:53+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-hana-securities-stepwise-loss-reduction-%c2%b7-strong-ess-bbu-shipments-%c2%b7-4q26-turnaround-2026-02-03/ 2026-08-22T07:01:05+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-kyobo-securities-gradual-loss-narrowing-%c2%b7-solid-state-battery-development-pipeline-%c2%b7-robotics-partnerships-2026-02-03/ 2026-08-22T06:59:22+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-ds-investment-securities-ess-revenue-surge-%c2%b7-4q26-turnaround-%c2%b7-physical-ai-expansion-with-46-series-all-solid-state-2026-02-03/ 2026-08-22T06:56:02+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-hanwha-investment-securities-us-ess-surges-%c2%b7-4q-lfp-ramp-up-%c2%b7-cyclical-bottom-passed-2026-02-03/ 2026-08-22T06:54:21+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-mirae-asset-securities-sdc-stake-monetization-%c2%b7-tesla-ess-business-expansion-%c2%b7-earnings-trough-2026-02-20/ 2026-08-22T06:52:29+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-hana-securities-sdc-stake-monetization-pursuit-%c2%b7-up-to-krw-11t-liquidity-%c2%b7-valuation-multiples-re-rating-2026-02-20/ 2026-08-22T06:50:13+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-mirae-asset-securities-bbu-momentum-%c2%b7-hungarian-utilization-rebound-%c2%b7-2026-operating-profit-turnaround-2026-03-18/ 2026-08-22T06:48:44+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-kyobo-securities-1q-trough-passing-%c2%b7-ess-utilization-gains-%c2%b7-humanoid-client-expansion-2026-03-30/ 2026-08-22T06:43:01+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-ibk-securities-fully-booked-north-america-ess-expected-%c2%b7-european-iaa-benefits-%c2%b7-1q-earnings-resilience-2026-04-02/ 2026-08-22T06:40:52+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-shinhan-securities-north-america-ess-surges-%c2%b7-bbu-demand-expansion-%c2%b7-turnaround-visibility-2026-04-20/ 2026-08-22T06:38:32+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-kiwoom-securities-ess-bbu-momentum-%c2%b7-europe-market-share-recovery-%c2%b7-4q26-turnaround-2026-04-29/ 2026-08-22T06:36:15+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-shinhan-securities-us-ess-demand-surges-%c2%b7-bbu-growth-%c2%b7-4q26-turnaround-2026-04-29/ 2026-08-22T06:34:33+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-im-securities-surging-aidc-ess-demand-%c2%b7-us-regulatory-tailwinds-%c2%b7-valuation-assessment-2026-04-29/ 2026-08-22T06:32:49+00:00 https://koreaequitylens.com/research-samsung-sdi-006400-ibk-securities-fully-booked-north-america-ess-%c2%b7-hungarian-utilization-recovery-%c2%b7-4q26-turnaround-2026-04-29/ 2026-08-22T06:30:38+00:00